Losartan-hctz 50-12.5 MG tab 90S
Ended Awarded
- Contract number
- SPE2DB25FZQ19
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,610
Award facts
- Contract value 100% obligated
- $2,610.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 17, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,610.48 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers 90 tablets of Losartan-HCT 50-12.5 mg, an antihypertensive medication commonly used in military and federal healthcare systems. This award was issued under a firm fixed-price contract structure with an ultimate completion date of September 18, 2025, with no set-aside designation utilized in the procurement.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and extending through November 2026. The IDC, part of the SPE2DB program, authorizes the DLA to issue firm fixed-price delivery orders for a comprehensive pharmaceutical supply portfolio supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for an extensive range of prescription medications, biologics, and medical consumables to support Department of Defense healthcare operations. The company's woman-owned small business status has enabled effective competition in federal procurement markets despite the absence of formal set-aside designations.
Quick answers
Who was awarded contract SPE2DB25FZQ19?
SPE2DB25FZQ19 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FZQ19 worth?
The government has obligated $2,610 on SPE2DB25FZQ19.
Is contract SPE2DB25FZQ19 an order under another contract?
Yes. SPE2DB25FZQ19 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZQ19 competed?
The extent of competition for SPE2DB25FZQ19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award